Abbvie Inc
ABBV
$195.22+6.20 (+3.28%)
Aug 2, 2025, 4:00 PM
Financials
| 52Week High | 218.66 | 52Week Low | 163.81 |
| Beta | 0.48 | Current Ratio Annual | 0.66 |
| Current Ratio Quarterly | 0.76 | Gross Margin TTM | 70.69 |
| Market Cap | 344.84B | Net Profit Margin TTM | 7.31 |
| Operating Margin TTM | 17.56 | Price To Book | 242.84 |
| Price To Earnings TTM | 82.20 | Price To Free Cash Flow TTM | 22.41 |
| Price To Sales TTM | 6.01 | Quick Ratio Annual | 0.43 |
| Quick Ratio Quarterly | 0.48 | Return On Assets TTM | 3.01 |
| Return On Equity TTM | 95.59 | Return On Investment TTM | 5.66 |
| Revenue Growth3Y | 0.08 | Revenue Growth5Y | 11.11 |
| Revenue Growth Quarterly Yoy | 8.39 | Revenue Growth TTMYoy | 5.45 |
| Revenue Per Share TTM | 32.37 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 3511 | 218 | 295 | 1387 | 1471 | 386 | 1.28B | $258.73B |
| Jun 30, 2025 | 1792 | 39 | 76 | 734 | 642 | 210 | 108.45M | $16.96B |
| Change | 1.72K(49%) | 179(82%) | 219(74%) | 653(47%) | 829(56%) | 176(46%) | 1.17B(92%) | $241.78B(93%) |